Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00199_DB00570_nanopub.RAwtUwcPL-GloRlzZd_1o0jCGQsaAqWOklW40-1Nhlau8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00199_DB00570 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00199_DB00570 label "DDI between Erythromycin and Vinblastine - Erythromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the vinblastine serum concentration and distribution in certain cells. Consider alternate therapy to avoid vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of vinblastine if erythromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00199_DB00570]" assertion.
- drugbank_resource:DB00199_DB00570 identifier "drugbank_resource:DB00199_DB00570" assertion.
- drugbank_resource:DB00199_DB00570 title "DDI between Erythromycin and Vinblastine - Erythromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the vinblastine serum concentration and distribution in certain cells. Consider alternate therapy to avoid vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of vinblastine if erythromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00570 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB00570 assertion.
- drugbank:DB00199 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00199_DB00570 assertion.